Researchers developed MAGIC, an AI-based system integrating automated microscopy and genomics to study chromosomal abnormalities linked to cancer.
Key Details
- 1MAGIC uses automated microscopy, AI-driven image analysis, and single-cell genome sequencing to identify and tag abnormal cells.
- 2The system can analyse nearly 100,000 cells in less than a day, vastly exceeding manual methods.
- 3Chromosomal abnormalities were seen in just over 10% of cell divisions, doubling with mutated p53 gene.
- 4MAGIC relies on a laser and photoconvertible dye to mark target cells, facilitating further analysis.
- 5The tool is versatile and can be trained to identify a variety of visually distinct cellular features.
Why It Matters
MAGIC represents a significant step forward in combining imaging AI and genomic methods for the high-throughput study of cellular abnormalities, offering potential advances in cancer detection and understanding cancer origins. Such AI-driven image analysis tools could pave the way for faster, more precise research and diagnostics in radiology and oncology.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.